Singapore, Aug. 14 -- UK-based Optellum and South Korea's Coreline Soft have announced their intent to collaborate across geographies and multiple disease areas to advance artificial intelligence (AI)-enabled lung cancer care across the lung nodule pathway.

Under the proposed collaboration, Optellum would make Coreline Soft's FDA-cleared computer-aided detection (CADe) software for lung nodules, AVIEW Lung Nodule CAD, available through LungOS(R), Optellum's end-to-end AI-powered platform for thoracic care.

The proposed collaboration is intended to connect Coreline Soft's FDA-cleared image-based CADe capability with Optellum's CADx, risk assessment, and care management workflow, supporting a more integrated pathway from detection to prio...